If.. you understand how far behind the US became in the 1990’s, you would understand why this US company will be rocketing straight up. Between training the docs who were kept in the dark on stem cell therapies by the AMA, driven by big pharma etc, USRM is a winner on all fronts. 10-43 dollars by June!